Journal article
Botulinum neurotoxin injection after total laryngectomy
Head & neck, Vol.19(2), pp.92-97
03/1997
DOI: 10.1002/(SICI)1097-0347(199703)19:2<92::AID-HED2>3.0.CO;2-P
PMID: 9059865
Abstract
Background
One of several causes of tracheoesophageal puncture (TEP) speech failure after total laryngectomy is disturbance in relaxation of the pharyngoesophageal (PE) segment. We introduce the use of chemical denervation of the PE segment through botulinum neurotoxin (Botox®) injection to improve TEP speech.
Methods
An analysis was performed on eight patients who received Botox® injections for TEP speech problems after total laryngectomy at the University of Iowa between June 4, 1991 and August 8, 1994. Retrospective chart review identified the evolution of pretreatment evaluation and injection technique which became standardized in April 1992. Prospective evaluation of results was recorded by a single speech pathologist who subjectively identified the response to Botox® in all patients and recorded pressure readings at the tracheostoma site during speech in 6 patients.
Results
Seven of the eight patients were noted to have improved TEP speech following injection. Five of these seven patients experienced substantially improved speech, three of whom had no ability to produce speech prior to the Botox® injection.
Conclusion
Botox® ingection is a safe and effective method of improving TEP speech in selected patients with disturbed relaxation of pharyngoesophageal segment. © 1997 John Wiley & Sons, Inc. Head Neck 19: 92–97, 1997.
Details
- Title: Subtitle
- Botulinum neurotoxin injection after total laryngectomy
- Creators
- Henry T HoffmanHeather FischerDuane VanDenmarkK. Linnea PetersonTimothy M McCullochLucy Hynds KarnellGerry F Funk
- Resource Type
- Journal article
- Publication Details
- Head & neck, Vol.19(2), pp.92-97
- DOI
- 10.1002/(SICI)1097-0347(199703)19:2<92::AID-HED2>3.0.CO;2-P
- PMID
- 9059865
- NLM abbreviation
- Head Neck
- ISSN
- 1043-3074
- eISSN
- 1097-0347
- Publisher
- Wiley Subscription Services, Inc., A Wiley Company; New York
- Number of pages
- 6
- Grant note
- National Institutes of Health (P60 DC00976)
- Language
- English
- Date published
- 03/1997
- Academic Unit
- Radiation Oncology; Otolaryngology
- Record Identifier
- 9984006343902771
Metrics
25 Record Views